Registry for managing Helicobacter pylori infection in Argentina

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to collect data on the management of Helicobacter pylori infections among Argentinean gastroenterologists. It focuses on understanding the effectiveness of various treatment regimens and the local antibiotic resistance profiles. By systematically documenting routine clinical practices, the registry seeks to identify optimal therapies that can be used empirically to improve eradication rates. The study will also explore the principles of antimicrobial stewardship to minimize inappropriate antibiotic use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Infected adult patients by Helicobacter pylori

\-

Exclusion Criteria:

Pregnant or lactating women Subjects currently taking any antibiotics Administration of antibiotics or bismuth in the preceding 4 weeks or PPI 2 weeks previous Unable or refuse to give consent

Where it's running

• Instituto de Investigaciones Medicas Alfredo Lanari. Universidad de Buenos Aires
  Ciudad de Buenos Aires, Argentina Recruiting

Study contacts

• Study coordinator: Oscar M Laudanno, MD
• Email: oscarlaudanno@gmail.com
• Phone: 5491141693149

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Carminal for H. pylori gastritis

  This trial will test if taking 30 ml daily of the Aloe vera–based supplement Carminal together with standard H. pylori therapy helps adults with H. pylori–positive gastritis heal their stomach lining better than standard therapy plus placebo.

  Recruiting at 2 sites Phase 2 Catalysis SL · Belgrade, Central Serbia and 1 other locations · NCT07179237

• How often H. pylori comes back and what affects its return.

  This project will follow adults aged 18–75 who were treated for H. pylori to see how often the infection returns and which eradication regimens lower that risk.

  Recruiting Sohag University · Sohag · NCT07045857

• Comparing vonoprazan-based dual and triple treatments with standard PPI triple therapy for H. pylori infection.

  We're testing whether vonoprazan-based dual or triple treatments clear H. pylori more effectively than the usual PPI triple therapy in adults who have never been treated for the infection.

  Recruiting Sohag University · Sohag · NCT07045688

• Eradicating H. Pylori with Argon Plasma During Endoscopy

  This study is testing a new argon plasma treatment during endoscopy to see if it can safely get rid of H. pylori infections in patients who haven't been treated yet.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06529159

• Screening and treating H. pylori to prevent gastric cancer in young adults

  This study is testing if screening and treating young adults for H. pylori can help prevent gastric cancer in people aged 30-34 in several European countries.

  Recruiting at 6 sites University of Latvia · Zagreb, City of Zagreb and 6 other locations · NCT06275204

• Comparing H. pylori screening strategies to prevent gastric cancer

  This project will test different ways to screen adults (age ≥20) for H. pylori who have never been screened or treated.

  Recruiting National Taiwan University Hospital · Taipei · NCT05387005

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.